4/23
08:12 am
rapp
Rapport Therapeutics (RAPP) had its "buy" rating reaffirmed by BTIG Research. They now have a $53.00 price target on the stock.
Medium
Report
Rapport Therapeutics (RAPP) had its "buy" rating reaffirmed by BTIG Research. They now have a $53.00 price target on the stock.
4/11
05:32 am
rapp
Rapport Therapeutics (RAPP) was upgraded by Raymond James Financial, Inc. to "strong-buy".
Low
Report
Rapport Therapeutics (RAPP) was upgraded by Raymond James Financial, Inc. to "strong-buy".
4/10
09:00 am
rapp
Rapport Therapeutics (RAPP) is now covered by Raymond James Financial, Inc.. They set a "strong-buy" rating and a $66.00 price target on the stock.
Low
Report
Rapport Therapeutics (RAPP) is now covered by Raymond James Financial, Inc.. They set a "strong-buy" rating and a $66.00 price target on the stock.
4/10
05:40 am
rapp
Rapport Therapeutics initiated with a Strong Buy at Raymond James
Low
Report
Rapport Therapeutics initiated with a Strong Buy at Raymond James
4/10
05:40 am
rapp
Rapport Therapeutics initiated with a Strong Buy at Raymond James
Low
Report
Rapport Therapeutics initiated with a Strong Buy at Raymond James
4/9
04:24 pm
rapp
Rapport Therapeutics initiated with a Strong Buy at Raymond James
Low
Report
Rapport Therapeutics initiated with a Strong Buy at Raymond James
4/9
04:24 pm
rapp
Rapport Therapeutics initiated with a Strong Buy at Raymond James
Low
Report
Rapport Therapeutics initiated with a Strong Buy at Raymond James
4/9
04:14 pm
rapp
Rapport Therapeutics initiated with a Strong Buy at Raymond James
Low
Report
Rapport Therapeutics initiated with a Strong Buy at Raymond James
4/9
04:14 pm
rapp
Rapport Therapeutics initiated with a Strong Buy at Raymond James
Low
Report
Rapport Therapeutics initiated with a Strong Buy at Raymond James
3/11
02:21 pm
rapp
Rating for RAPP
Low
Report
Rating for RAPP
3/11
11:08 am
rapp
Rating for RAPP
Low
Report
Rating for RAPP
3/11
11:08 am
rapp
Rating for RAPP
Low
Report
Rating for RAPP
3/10
10:15 am
rapp
Rapport Therapeutics (RAPP) had its "market outperform" rating reaffirmed by Citigroup Inc..
Medium
Report
Rapport Therapeutics (RAPP) had its "market outperform" rating reaffirmed by Citigroup Inc..
3/9
11:05 am
rapp
Rapport Therapeutics (RAPP) had its "buy" rating reaffirmed by BTIG Research.
Low
Report
Rapport Therapeutics (RAPP) had its "buy" rating reaffirmed by BTIG Research.
2/2
09:46 am
rapp
Rating for RAPP
Low
Report
Rating for RAPP
2/2
09:46 am
rapp
Rating for RAPP
Low
Report
Rating for RAPP
2/2
07:00 am
rapp
Rapport Therapeutics (NASDAQ:RAPP) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $43.00 price target on the stock.
Medium
Report
Rapport Therapeutics (NASDAQ:RAPP) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $43.00 price target on the stock.
2/2
05:58 am
rapp
Rapport Therapeutics initiated with an Overweight at Wells Fargo
Medium
Report
Rapport Therapeutics initiated with an Overweight at Wells Fargo
2/2
05:58 am
rapp
Rapport Therapeutics initiated with an Overweight at Wells Fargo
Medium
Report
Rapport Therapeutics initiated with an Overweight at Wells Fargo